An interventional study of hydroxypropylmethylcellulose and sodium hyaluronate in Ocular Surface Disease and Glaucoma, sponsored by Mahidol University. Status unknown at 1 site in Thailand. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-01-27.
Sponsored by Mahidol University · Not applicable, Interventional, and Treatment
To study effect of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% in the treatment of ocular surface disease in glaucoma patients.
1,818 studies on the registry are indexed under Glaucoma; 231 are open to participants now.
This study's planned enrollment of 120 is above the median of 65 across 1,272 interventional studies indexed under Glaucoma.
Browse Glaucoma studies →Mahidol University is the lead sponsor of 730 studies on the registry; 118 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: hydroxypropylmethylcellulose
Drug: sodium hyaluronate
TearA: QID to every 2 hous , 1-2 drops per each time , duration 1 month
QID to every 2 hous, 1-2 drops per each time, duration 1 month
Ocular surface index score
Time frame: 1 month
Eye lid inflammation, corneal staining score, tear break up time and tear volume
Time frame: 1 month
This study is status unknown, as verified in Jan 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mahidol University